Medinex Limited
Medinex Limited Fundamental Analysis
Medinex Limited (OTX.SI) shows moderate financial fundamentals with a PE ratio of 14.82, profit margin of 22.05%, and ROE of 12.83%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 71.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze OTX.SI's fundamental strength across five key dimensions:
Efficiency Score
ExcellentOTX.SI demonstrates superior asset utilization.
Valuation Score
ExcellentOTX.SI trades at attractive valuation levels.
Growth Score
ModerateOTX.SI shows steady but slowing expansion.
Financial Health Score
ExcellentOTX.SI maintains a strong and stable balance sheet.
Profitability Score
ModerateOTX.SI maintains healthy but balanced margins.
Key Financial Metrics
Is OTX.SI Expensive or Cheap?
P/E Ratio
OTX.SI trades at 14.82 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, OTX.SI's PEG of 0.50 indicates potential undervaluation.
Price to Book
The market values Medinex Limited at 1.89 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 15.24 times EBITDA. This signals the market has high growth expectations.
How Well Does OTX.SI Make Money?
Net Profit Margin
For every $100 in sales, Medinex Limited keeps $22.05 as profit after all expenses.
Operating Margin
Core operations generate 37.79 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $12.83 in profit for every $100 of shareholder equity.
ROA
Medinex Limited generates $10.30 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Medinex Limited generates strong operating cash flow of $2.65M, reflecting robust business health.
Free Cash Flow
Medinex Limited generates strong free cash flow of $2.64M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.02 in free cash annually.
FCF Yield
OTX.SI converts 8.80% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
14.82
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.50
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.89
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.18
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.10
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.59
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.21
vs 25 benchmark
How OTX.SI Stacks Against Its Sector Peers
| Metric | OTX.SI Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 14.82 | 28.31 | Better (Cheaper) |
| ROE | 12.83% | 699.00% | Weak |
| Net Margin | 22.05% | -130884.00% (disorted) | Strong |
| Debt/Equity | 0.10 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 2.59 | 2775.16 | Strong Liquidity |
| ROA | 10.30% | -14469.00% (disorted) | Strong |
OTX.SI outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Medinex Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation